The venture capital arms of MSD and Amgen have provided $10 million in funding to Culmination Bio, a Utah start-up that aims to build the largest disease-agnostic patient
NHS England has awarded US IT group Palantir the contract to create a new federated data platform (FDP) designed to bring together existing NHS data into a single framewor
Modern medicine moves ever more to precision, personalised medicine, and precision dosing is critical in a world that recognises biological individuality – especially when it comes to paedi
